| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6f93f1f1ac8b42bc864afbe6265fd8a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90 |
| filingDate |
1995-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ebb1494b08ac1cca72b3dd6ddd626e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1336dde87030f5c4027161f52b72ab2 |
| publicationDate |
2004-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0761251-B1 |
| titleOfInvention |
Drug-releasing stent |
| abstract |
A stent according to the present invention is adapted to be introduced into a vascular system such as blood vessels. The stent includes a stent body produced by weaving or knitting a fiber containing a drug and made of a low-melting biodegradable polymer into a tubular shape, or coating a drug-containing low-melting biodegradable polymer on a stent body. When the stent is introduced into the vascular system, the drug contained therein is dosed in a locally limited region of the vascular system. The low-melting biodegradable polymer used has a melting point of 80° C or lower and is at least one compound selected from the group consisting of poly-E-caprolactone, poly-D, L-deca-lactone, poly-dioxane and a copolymer thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7842083-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8439968-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8052734-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8052735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187321-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-303081-B6
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7850727-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7850728-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7896912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7819912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303609-B2 |
| priorityDate |
1994-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |